相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Jeffrey M. Riggs et al.
LUPUS SCIENCE & MEDICINE (2018)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody
Li Peng et al.
MABS (2015)
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Advances in understanding the role of type I interferons in systemic lupus erythematosus
Mary K. Crow
CURRENT OPINION IN RHEUMATOLOGY (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Emerging therapies for systemic lupus erythematosus - Focus on targeting interferon-alpha
Eben I. Lichtman et al.
CLINICAL IMMUNOLOGY (2012)
Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus
Mariana Postal et al.
CLINICS (2012)
Glucocorticoid use and abuse in SLE
Guillermo Ruiz-Irastorza et al.
RHEUMATOLOGY (2012)
Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
Rachel Klein et al.
ARCHIVES OF DERMATOLOGY (2011)
Contemporary treatment of systemic lupus erythematosus: an update for clinicians
Maame B. Amissah-Arthur et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2010)
Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
Richard A. Furie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Revised British isles lupus assessment group 2004 index - A reliable tool for assessment of systemic lupus erythematosus activity
Chee-Seng Yee et al.
ARTHRITIS AND RHEUMATISM (2006)
Systemic lupus erythematosus
Jessica J. Manson et al.
ORPHANET JOURNAL OF RARE DISEASES (2006)
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
J Albrecht et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2005)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
